Pathogenetic significance of transforming growth factor β1 in patients with colorectal cancer
Aim. We aimed to evaluate levels of transforming growth factor β1 (TGF-β1) in the serum, lymph nodes, and primary tumour in patients with colorectal cancer.Materials and Methods. Here we enrolled 44 patients with colorectal cancer and 25 patients with benign tumours of the colon admitted to Chita Re...
Saved in:
| Main Authors: | A. V. Chetveryakov, V. L. Tsepelev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Kemerovo State Medical University
2022-10-01
|
| Series: | Фундаментальная и клиническая медицина |
| Subjects: | |
| Online Access: | https://fcm.kemsmu.ru/jour/article/view/568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Correlation between Transforming Growth Factor-Beta (TGF- β) Serum Level and Beck Depression Inventory (BDI) Score in Colorectal Cancer Patients at RSMH Palembang
by: Muhammad Ali Apriansyah, et al.
Published: (2020-06-01) -
Prkci promotes colorectal cancer metastasis by phosphorylating and stabilizing Tgfbr1 to activate TGF-β signaling
by: Peng Li, et al.
Published: (2025-05-01) -
Prognostic value of the levels of CTLA-4 and its ligand B7.2 in patients with colorectal cancer
by: A. V. Chetveryakov, et al.
Published: (2023-07-01) -
Expression of individual members of the TGF-β/SMAD signalling pathway in the progression and survival of patients with colorectal carcinoma
by: Ivana Večurkovská, et al.
Published: (2024-11-01) -
Transforming growth factor β1 gene polymorphism in postmenopausal osteoporosis
by: M Y Krylov, et al.
Published: (2009-02-01)